EoE: Not just an elimination diet, for an elimination diet that works

Published Date: 08 Mar 2023

Eliminating milk alone not only reduces the symptoms of patients with eosinophilic esophagitis, but also improves quality of life.

Read Full News

Latest News

WHO's Tedros Says Uganda Should Reconsider Congo Border Closure Over Ebola

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

AI Brings Oxygen Therapy Closer to Autopilot

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

Ontario Researchers Discover Promising Antibiotic

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

Lyme Primer: How the HHS Strategy Stacks Up To Science

Experts support targeting ticks but caution against the long-term use of antibiotics.

TNFi Use in Early Peripheral SpA Outperforms Methotrexate

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

FDA Approves First New Sunscreen Option in Two Decades

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Latest News

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

Experts support targeting ticks but caution against the long-term use of antibiotics.

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

News All Time

SARS-CoV-2 Poses Greater Autoimmune Risk Than Vaccines

Spanish dermatologists report that vaccine-related skin eruptions are uncommon, while SARS-CoV-2 infection itself is more strongly linked to autoimmune and vascular complications.

When Your Loved Ones Trust TikTok Over Their Doctor — & You

Physicians recount how health disinformation damaged close relationships and forced them to rethink how to advise loved ones.

Bimekizumab Trumps Risankizumab in Head-to-Head PsA Trial

Dual IL-17A/F inhibition was superior to IL-23 inhibition for managing joint involvement in psoriatic arthritis, according to findings from the phase 3b BE BOLD study.

Professional Corner: Groups Decry Medicaid Work Requirement

Societies say a federal policy may reduce access to care. The American Academy of Pediatrics updates its guidance on generic drugs. And a new research network focuses on heart transplant outcomes.

Why Cosmetic Surgery Abroad Can Backfire

Lower prices are drawing patients abroad for cosmetic surgery, but variable surgical expertise, limited follow-up care, and serious postoperative complications can quickly erase the savings.

Mepolizumab Boosts Quality of Life in CRSwNP

Mepolizumab improves disease-specific quality of life, reduces polyp burden, and improves asthma control in patients with severe chronic rhinosinusitis with nasal polyps, a real-world study shows.

Early Eosinophil Counts Affect Asthma in Pregnancy

Periconception levels show potential as a clinically useful marker for patients at risk.

MHRA Begins Review of Avacopan for Autoimmune Vasculitis

The UK’s drugs regulator is reviewing the integrity of trial data underpinning avacopan's licence for ANCA-associated vasculitis.

Ruto Says US Plan to Build Ebola Facility in Kenya Is the 'right Thing'

Kenyan President William Ruto on Thursday said his government was doing "the right thing" by allowing the United States to set up an Ebola quarantine facility ⁠in...

US Domestic Treatment Centers Ready for Ebola Even as Kenya Plans Persist

Most of the 13 U.S. treatment centers in a government-funded hospital network for severe infectious diseases are ready to handle patients, including those with Ebola if...

Otsuka Says Kidney Disease Drug Preserves Function in Late-stage Study

Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney ⁠function over 12 months in patients with a type of autoimmune disease that affects...

How Doctors’ Regrets Evolve — and What to Do With Yours

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Obexelimab Lowers Flare Risk in Phase 3 IgG4-RD Trial

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic steroid exposure in patients with active IgG4-related disease.

Anifrolumab Improves Multiple Sjögren Disease Measures

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease.

JAK1 Inhibitor Zemprocitinib Hits Targets in Refractory RA

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Infection Risk in Lupus and RA: What Matters Most

Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with new data highlighting where clinicians should focus.

Recommended News For You

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

Mapping lifelong chronic health risks for childhood cancer survivors

New study elucidates obesity's role in fueling breast cancer progression

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

Recommended Articles For You

Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained 

Uncovering New Hope for Follicular Lymphoma Patients 

Survival Rate Dynamics in Hematologic and Solid Malignancies 

Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Surgery may not be necessary to treat invasive breast cancer

2.

Early Results for Anorexia Nervosa with Psilocybin.

3.

A protein with new anticancer activity has been identified

4.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

5.

Chemotherapy Boosts Survival for Older Patients With TNBC

1.

Navigating the Unknown: How to Cope with Anaplastic Thyroid Cancer

2.

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training

3.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

4.

Navigating the Complexities of Esophageal Cancer Staging

5.

Discovering the Benefits of TNK: A Comprehensive Blog Article 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

3.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

4.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

5.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot